Breaking News Instant updates and real-time market news.

TSLA

Tesla

$352.08

-18.12 (-4.89%)

21:00
08/09/18
08/09
21:00
08/09/18
21:00

Tesla board states that CEO Musk has 'addressed the funding', Reuters says

Tesla board of directors intends to meet with CEO Musk about his plans to take the company private, Reuters says in a follow-up to an earlier CNBC report, citing people familiar with discussions. The board has indicated that in its discussions with Musk, he has "addressed the funding" for the deal, and its meeting will seek more details on how the deal will be financed. Reference Link

  • 29

    Oct

TSLA Tesla
$352.08

-18.12 (-4.89%)

08/08/18
MSCO
08/08/18
NO CHANGE
Target $291
MSCO
Equal Weight
Musk may want to take Tesla private, but Morgan Stanley questions feasibility
While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questions the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." The benefits of being private are outweighed by the risks of added financial leverage, which could be even more strategically limiting, added Jonas, who keeps an Equal Weight rating on Tesla shares with a price target of $291.
08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.

TODAY'S FREE FLY STORIES

LBTYA

Liberty Global

$28.37

-0.87 (-2.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Liberty Global management to meet with Wolfe Research »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

TRU

TransUnion

$73.68

-0.62 (-0.83%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TransUnion management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 23

    Oct

NNBR

NN, Inc.

$15.65

-0.05 (-0.32%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
NN, Inc. to host two day investor day »

Two day investor day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

CLAR

Clarus Corporation

$10.45

-0.3 (-2.79%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Clarus Corporation management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AMSC

AMSC

$6.33

-0.265 (-4.02%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AMSC management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TSLX

TPG Specialty Lending

$20.56

-0.15 (-0.72%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

THR

Thermon Group

$25.98

-0.14 (-0.54%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Thermon Group management to meet with William Blair »

Group luncheon with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

September Richmond Fed…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AdvaMed to hold a conference »

MedTech Conference will…

IMPV

Imperva

$46.70

1.05 (2.30%)

, FIVN

Five9

$43.51

0.3 (0.69%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$46.70

1.05 (2.30%)

FIVN

Five9

$43.51

0.3 (0.69%)

CDAY

Ceridian

$42.29

0.225 (0.53%)

MSFT

Microsoft

$114.72

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

TEN

Tenneco

$44.59

-0.9 (-1.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Tenneco management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Oct

SWCH

Switch

$10.85

-0.21 (-1.90%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SRNE

Sorrento Therapeutics

$4.23

-0.075 (-1.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Sorrento Therapeutics management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$78.75

2.44 (3.20%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Exact Sciences management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KRYS

Krystal Biotech

$17.68

0.8 (4.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Krystal Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

GMED

Globus Medical

$54.09

-0.04 (-0.07%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Globus Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

CZWI

Citizens Community Bancorp

$14.09

-0.04 (-0.28%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABT

Abbott

$71.43

2.38 (3.45%)

, ABMD

Abiomed

$419.53

34.84 (9.06%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Cardiovascular Research Foundation »

TCT 2018 will be held in…

ABT

Abbott

$71.43

2.38 (3.45%)

ABMD

Abiomed

$419.53

34.84 (9.06%)

AMGN

Amgen

$207.30

2.25 (1.10%)

AZN

AstraZeneca

$37.84

0.155 (0.41%)

BSX

Boston Scientific

$38.39

0.63 (1.67%)

CAE

CAE

$20.10

-0.345 (-1.69%)

CAJ

Canon

$31.52

-0.165 (-0.52%)

CSII

Cardiovascular Systems

$37.16

0.42 (1.14%)

EW

Edwards Lifesciences

$165.52

11.81 (7.68%)

HCA

HCA Healthcare

$134.31

0.95 (0.71%)

ICLR

Icon

$149.62

-0.54 (-0.36%)

LIVN

LivaNova

$124.79

2.46 (2.01%)

MDT

Medtronic

$98.85

1 (1.02%)

PHG

Philips

$45.68

-0.18 (-0.39%)

REGN

Regeneron

$390.39

-0.16 (-0.04%)

SNY

Sanofi

$43.40

-0.21 (-0.48%)

SIEGY

Siemens

$0.00

(0.00%)

TFX

Teleflex

$268.91

-0.84 (-0.31%)

VBLT

VBL Therapeutics

$1.58

-0.025 (-1.56%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 09

    Oct

  • 11

    Oct

  • 17

    Oct

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

  • 27

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

LLESY

Lendlease Group

$0.00

(0.00%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Lendlease Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

NGG

National Grid

$51.46

-0.62 (-1.19%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
National Grid management to meet with JPMorgan »

Meetings to be held New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

YGYI

Youngevity

$5.80

0.8 (16.00%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Youngevity management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

ANTM

Anthem

$273.26

0.5 (0.18%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Anthem management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

WTW

Weight Watchers

$72.88

3.11 (4.46%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Weight Watchers management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

STRA

Strategic Education

$137.53

0.72 (0.53%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Strategic Education management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
General news
Consumer Confidence to be reported at 10:00 »

September Consumer…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.